Seereverse Niketa Patel
FDA investigator
Appears on 1 document from 2018, mostly at sites in China. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 2.0
- Observations per 483
- 2018
- First seen
- 2018
- Most recent
What they cite most
From 2 observations- 21 CFR 211.160General requirements1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.194Laboratory records1
Activity by year
2018: 1
Where
China 1
Is Seereverse Niketa Patel coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-08-24 | 483 Changzhou Maokang Medical Products Co., LtdAug 24, 2018 · Changzhou, China | Changzhou, China | 2 |
About this profile
What does Seereverse Niketa Patel inspect?
Seereverse Niketa Patel appears on 1 document on file covering 1 site, mostly in China.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.165 and 21 CFR 211.194.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Seereverse Niketa Patel is dated Aug 24, 2018.